Genomill: Mike Doherty

Genomill has appointed Mike Doherty, the former head of product development at Foundation Medicine to its board of directors. In addition to serving on the board, Doherty will also be a strategic advisor as Genomill prepares to commercialize its Geno1 technology, a pre-sequencing platform to improve cost, performance, and scalability of next-generation sequencing.